Sabra Health Care REIT’s (SBRA) “Neutral” Rating Reaffirmed at Mizuho

Mizuho restated their neutral rating on shares of Sabra Health Care REIT (NASDAQ:SBRA) in a research note published on Thursday, Marketbeat Ratings reports. Mizuho currently has a $20.00 price objective on the real estate investment trust’s stock.

SBRA has been the subject of a number of other research reports. Citigroup raised shares of Sabra Health Care REIT from a “neutral” rating to a “buy” rating and raised their target price for the company from $17.00 to $20.00 in a research note on Friday, September 13th. Truist Financial raised their target price on shares of Sabra Health Care REIT from $16.00 to $18.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. Wells Fargo & Company raised shares of Sabra Health Care REIT from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $16.00 to $20.00 in a research note on Tuesday, October 1st. Finally, Scotiabank raised their target price on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the company a “sector perform” rating in a research note on Friday, October 11th. Two equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, Sabra Health Care REIT presently has a consensus rating of “Moderate Buy” and an average price target of $19.14.

Sabra Health Care REIT Stock Performance

Shares of SBRA opened at $18.26 on Thursday. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.16 and a quick ratio of 4.16. Sabra Health Care REIT has a one year low of $12.83 and a one year high of $20.03. The company has a 50-day simple moving average of $18.61 and a two-hundred day simple moving average of $16.92. The firm has a market capitalization of $4.32 billion, a PE ratio of 44.54, a price-to-earnings-growth ratio of 2.32 and a beta of 1.24.

Sabra Health Care REIT (NASDAQ:SBRA) last announced its earnings results on Thursday, October 31st. The real estate investment trust reported $0.13 earnings per share for the quarter, missing analysts’ consensus estimates of $0.35 by ($0.22). Sabra Health Care REIT had a net margin of 14.20% and a return on equity of 3.51%. The business had revenue of $178.00 million for the quarter, compared to the consensus estimate of $177.19 million. During the same period in the prior year, the business posted $0.34 EPS. On average, analysts anticipate that Sabra Health Care REIT will post 1.39 EPS for the current fiscal year.

Sabra Health Care REIT Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, November 29th. Shareholders of record on Friday, November 15th were paid a dividend of $0.30 per share. The ex-dividend date was Friday, November 15th. This represents a $1.20 dividend on an annualized basis and a yield of 6.57%. Sabra Health Care REIT’s dividend payout ratio is presently 292.69%.

Institutional Investors Weigh In On Sabra Health Care REIT

A number of hedge funds have recently added to or reduced their stakes in SBRA. Wellington Management Group LLP raised its stake in Sabra Health Care REIT by 736.5% during the 3rd quarter. Wellington Management Group LLP now owns 2,396,835 shares of the real estate investment trust’s stock valued at $44,605,000 after buying an additional 2,110,307 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Sabra Health Care REIT by 324.3% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,404,576 shares of the real estate investment trust’s stock valued at $26,139,000 after buying an additional 1,073,530 shares during the last quarter. Point72 Asset Management L.P. raised its stake in Sabra Health Care REIT by 152.7% during the 2nd quarter. Point72 Asset Management L.P. now owns 1,732,274 shares of the real estate investment trust’s stock valued at $26,677,000 after buying an additional 1,046,748 shares during the last quarter. Thrivent Financial for Lutherans raised its stake in Sabra Health Care REIT by 1,557.9% during the 3rd quarter. Thrivent Financial for Lutherans now owns 927,309 shares of the real estate investment trust’s stock valued at $17,258,000 after buying an additional 871,375 shares during the last quarter. Finally, Millennium Management LLC purchased a new stake in Sabra Health Care REIT during the 2nd quarter valued at $12,972,000. 99.40% of the stock is currently owned by hedge funds and other institutional investors.

About Sabra Health Care REIT

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.